Sunday, 5 July 2009

All Ireland chronic lymphocytic leukaemia conference held in Dublin

The story of CLL biology and therapy is just beginning and we can expect “more exciting progress in the next decade,” according to Prof Kanti Rai, chief of haematology and oncology at the Long Island Jewish Medical Centre in New York, US, who was a guest speaker at the recent All Ireland Conference on the Management of Chronic Lymphocytic Leukaemia (CLL).

Click here to read more.

(Content from the Irish Medical News)

No comments: